IP Group Yönetim

Yönetim kriter kontrolleri 4/4

IP Group CEO'su Greg Smith, Oct2021 tarihinde atandı, in görev süresi 3.08 yıldır. in toplam yıllık tazminatı £ 765.00K olup, şirket hissesi ve opsiyonları dahil olmak üzere 70.7% maaş ve 29.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.053% ine doğrudan sahiptir ve bu hisseler € 269.39K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.8 yıl ve 6.3 yıldır.

Anahtar bilgiler

Greg Smith

İcra Kurulu Başkanı

UK£765.0k

Toplam tazminat

CEO maaş yüzdesi	70.7%
CEO görev süresi	3.1yrs
CEO sahipliği	0.05%
Yönetim ortalama görev süresi	7.8yrs
Yönetim Kurulu ortalama görev süresi	6.3yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Greg Smith'un ücretlendirmesi IP Group'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-UK£226m
Mar 31 2024	n/a	n/a	-UK£199m
Dec 31 2023	UK£765k	UK£541k	-UK£171m
Sep 30 2023	n/a	n/a	-UK£130m
Jun 30 2023	n/a	n/a	-UK£88m
Mar 31 2023	n/a	n/a	-UK£215m
Dec 31 2022	UK£958k	UK£525k	-UK£342m
Sep 30 2022	n/a	n/a	-UK£157m
Jun 30 2022	n/a	n/a	UK£28m
Mar 31 2022	n/a	n/a	UK£238m
Dec 31 2021	UK£730k	UK£354k	UK£449m
Sep 30 2021	n/a	n/a	UK£367m
Jun 30 2021	n/a	n/a	UK£285m
Mar 31 2021	n/a	n/a	UK£235m
Dec 31 2020	UK£600k	UK£293k	UK£185m
Sep 30 2020	n/a	n/a	UK£84m
Jun 30 2020	n/a	n/a	-UK£17m
Mar 31 2020	n/a	n/a	-UK£46m
Dec 31 2019	UK£386k	UK£279k	-UK£75m
Sep 30 2019	n/a	n/a	-UK£197m
Jun 30 2019	n/a	n/a	-UK£319m
Mar 31 2019	n/a	n/a	-UK£306m
Dec 31 2018	UK£352k	UK£273k	-UK£294m
Sep 30 2018	n/a	n/a	-UK£140m
Jun 30 2018	n/a	n/a	UK£14m
Mar 31 2018	n/a	n/a	UK£32m
Dec 31 2017	UK£443k	UK£259k	UK£50m

Tazminat ve Piyasa: Greg 'ın toplam tazminatı ($USD 961.39K ) German pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.03M ).

Tazminat ve Kazançlar: Greg 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Greg Smith (46 yo)

3.1yrs

Görev süresi

UK£765,000

Tazminat

Mr. Gregory Simon Smith, also known as Greg, A.C.A, serves as Director at Longview Innovation Corp. (formerly known as IP Group, Inc.). He serves as Managing Director & Head of UK Wholesale Distribution at...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Gregory Smith	CEO & Executive Director	3.1yrs	UK£765.00k	0.053% € 269.4k
David Baynes	COO, CFO	10.6yrs	UK£560.00k	0.046% € 236.7k
Eoin Murphy	Group Head of IT & Operations	no data	Veri yok	Veri yok
Angela Leach	General Counsel & Company Secretary	16.8yrs	Veri yok	0.029% € 150.4k
Helen Redmond	Senior Compliance & Risk Manager	no data	Veri yok	Veri yok
Liz Vaughan-Adams	Director of Communications	18.8yrs	Veri yok	Veri yok
Anthony York	Group People Director	2.7yrs	Veri yok	Veri yok
Stuart Thompson	Talent Partner & Head of IP Exec	no data	Veri yok	Veri yok
Mark Reilly	Managing Partner	no data	Veri yok	0.0038% € 19.4k
Samuel Williams	Managing Partner	no data	Veri yok	0.011% € 56.3k
Joyce Xie	Managing Director of Global Capital	no data	Veri yok	Veri yok
Lee Thornton	Partner of Technology	5yrs	Veri yok	Veri yok

7.8yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim: IOOA 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Gregory Smith	CEO & Executive Director	13.4yrs	UK£765.00k	0.053% € 269.4k
David Baynes	COO, CFO	10.7yrs	UK£560.00k	0.046% € 236.7k
Samuel Williams	Managing Partner	6.8yrs	Veri yok	0.011% € 56.3k
Douglas Flint	Independent Non-Executive Chairman	6.2yrs	UK£218.00k	0.0095% € 48.8k
Aedhmar Hynes	Senior Independent Non-Executive Director	5.3yrs	UK£96.00k	0.0021% € 10.8k
Caroline Brown	Independent Non-Executive Director	5.3yrs	UK£75.00k	Veri yok
Heejae Chae	Independent Non-Executive Director	6.5yrs	UK£66.00k	0.0032% € 16.6k
Anita Kidgell	Independent Non-executive Director	1.8yrs	UK£53.00k	Veri yok

6.3yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IOOA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.3 yıldır).

IP Group Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

CEO & Executive Director recently sold €114k worth of stock

IP Group Plc, Annual General Meeting, Jun 12, 2024

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Insufficient new directors

Insider recently bought €51k worth of stock

Insufficient new directors

Recent updates

Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

First half 2024 earnings released: UK£0.11 loss per share (vs UK£0.053 loss in 1H 2023)

New major risk - Revenue and earnings growth

IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024

New minor risk - Share price stability

Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO).

CEO & Executive Director recently sold €114k worth of stock

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

New minor risk - Share price stability

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

IP Group Plc, Annual General Meeting, Jun 12, 2024

New minor risk - Financial data availability

IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024

IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023.

New minor risk - Share price stability

First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022)

IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023

Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021)

IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023

Scaleworks Inc. acquired Import.io Ltd.

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Insufficient new directors

Insider recently bought €51k worth of stock

Insufficient new directors

Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed

First half 2022 earnings released

IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022

IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022

IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022

Investor sentiment deteriorated over the past week

Insider recently bought €72k worth of stock

Executive Officer recently bought €59k worth of stock

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020)

NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.

IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited.

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Revenue beats expectations

IP Group Plc, Annual General Meeting, Jun 09, 2021

New 90-day high: €1.44

IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021

Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO).

New 90-day high: €1.25

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş